This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Kairat Madin: Innovator in Immunoglobulin Encoding Nucleic Acids
Introduction: Kairat Madin, based in Penzberg, Germany, is an accomplished inventor known for his significant contribution to the field of immunology through his innovative patent. His work focuses on the methodology for obtaining nucleic acids that encode immunoglobulin variable domains, a crucial aspect of modern biomedical research.
Latest Patents: Kairat Madin holds one patent titled "Method for obtaining immunoglobulin encoding nucleic acid." This pioneering invention outlines a novel method utilizing a two-step polymerase chain reaction process. The method begins with a first PCR that employs three to six 5'-primers and one 3'-primer, followed by a second PCR that uses thirteen to sixteen 5'-primers and one 3'-primer. This innovative approach effectively reduces the distance between the binding locations of primers in the second reaction compared to the first, enhancing the efficiency and specificity of the nucleic acid synthesis.
Career Highlights: Kairat is currently associated with Hoffmann-La Roche Inc., a leading global healthcare company renowned for its contributions to pharmaceuticals and diagnostics. His work at the company reflects his commitment to advancing biomedical innovation and research, contributing to the development of cutting-edge treatments and therapies.
Collaborations: Throughout his career, Kairat has collaborated with notable peers, including Hans-Willi Krell and Alexander Lifke. These collaborations have fostered a dynamic environment for research and innovation, enabling the team to push the boundaries of scientific knowledge and application in immunology.
Conclusion: Kairat Madin’s work exemplifies the intersection of innovation and scientific advancement in the field of immunology. His patent not only showcases his ingenuity as an inventor but also highlights his contributions to enhancing the methods of obtaining nucleic acids, which hold significant implications for future biomedical applications. As he continues his work at Hoffmann-La Roche Inc., Kairat remains a pivotal figure in the improvement of healthcare solutions through innovative research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile